You are here

Balanced approach

Takeda CEO Christophe Weber tells how he manages tensions in everything from drug pricing to the world's largest acquisition in 2018: Takeda's takeover of biotech company Shire.

"There will be a lot of innovation, but healthcare systems are struggling to keep up. And often in many countries, there is an ageing population. It's a demographic evolution that's not helping. That's the tension that we'll have to manage in the future." - Takeda CEO Christophe Weber.

THERE is a delicate balance to strike when one is a Frenchman heading a 238-year-old corporation in Japan, a country where foreigners are still a rare breed among chief executives. And when one's mission is to globalise the business without destroying a deeply rooted culture, it can be hard to...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to